BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22385196)

  • 1. Kindling translational cancer nanotechnology research.
    Chapman S; Panaro NJ; Hinkal GW; Hook SS; Prabhakar U; Ptak K; Farrell D; Grodzinski P
    Nanomedicine (Lond); 2012 Mar; 7(3):321-5. PubMed ID: 22385196
    [No Abstract]   [Full Text] [Related]  

  • 2. Future opportunities in cancer nanotechnology--NCI strategic workshop report.
    Grodzinski P; Farrell D
    Cancer Res; 2014 Mar; 74(5):1307-10. PubMed ID: 24413533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicine and society.
    Ferrari M; Philibert MA; Sanhai WR
    Clin Pharmacol Ther; 2009 May; 85(5):466-7. PubMed ID: 19381150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances from the National Cancer Institute Alliance for Nanotechnology in Cancer.
    Farrell D; Alper J; Ptak K; Panaro NJ; Grodzinski P; Barker AD
    ACS Nano; 2010 Feb; 4(2):589-94. PubMed ID: 20175564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care.
    Hartshorn CM; Bradbury MS; Lanza GM; Nel AE; Rao J; Wang AZ; Wiesner UB; Yang L; Grodzinski P
    ACS Nano; 2018 Jan; 12(1):24-43. PubMed ID: 29257865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National Cancer Institute Alliance for nanotechnology in cancer-Catalyzing research and translation toward novel cancer diagnostics and therapeutics.
    Hartshorn CM; Russell LM; Grodzinski P
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Nov; 11(6):e1570. PubMed ID: 31257722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of nanotechnology in cancer research: review of progress in the National Cancer Institute's Alliance for Nanotechnology.
    Ehdaie B
    Int J Biol Sci; 2007 Jan; 3(2):108-10. PubMed ID: 17304339
    [No Abstract]   [Full Text] [Related]  

  • 8. Europe as leaders in nanomedicine: let's go for it!
    Lévy L
    Nanomedicine (Lond); 2014 Apr; 9(4):389-91. PubMed ID: 24787438
    [No Abstract]   [Full Text] [Related]  

  • 9. NCI Alliance for Nanotechnology in Cancer - from academic research to clinical interventions.
    Grodzinski P; Liu CH; Hartshorn CM; Morris SA; Russell LM
    Biomed Microdevices; 2019 Mar; 21(2):32. PubMed ID: 30904965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small scale cancer fighters. Advances in nanotechnology offer hope for more effective and less toxic treatments.
    Printz C
    Cancer; 2008 Oct; 113(7):1497-8. PubMed ID: 18800391
    [No Abstract]   [Full Text] [Related]  

  • 11. From the editor. Translational Research Working Group roadmaps for cancer research.
    Bates SE
    Clin Cancer Res; 2008 Sep; 14(18):5663. PubMed ID: 18794073
    [No Abstract]   [Full Text] [Related]  

  • 12. Multifunctional radionanomedicine: a novel nanoplatform for cancer imaging and therapy.
    Muthu MS; Wilson B
    Nanomedicine (Lond); 2010 Feb; 5(2):169-71. PubMed ID: 20148628
    [No Abstract]   [Full Text] [Related]  

  • 13. The NCI Alliance for Nanotechnology in Cancer: achievement and path forward.
    Ptak K; Farrell D; Panaro NJ; Grodzinski P; Barker AD
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(5):450-60. PubMed ID: 20552623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating Nanotechnology into Cancer Care.
    Grodzinski P; Kircher M; Goldberg M; Gabizon A
    ACS Nano; 2019 Jul; 13(7):7370-7376. PubMed ID: 31240914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highlights of recent developments and trends in cancer nanotechnology research--view from NCI Alliance for Nanotechnology in Cancer.
    Hull LC; Farrell D; Grodzinski P
    Biotechnol Adv; 2014; 32(4):666-78. PubMed ID: 23948249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnology and cancer nanomedicine.
    Liang XJ
    Biotechnol Adv; 2014; 32(4):665. PubMed ID: 24913056
    [No Abstract]   [Full Text] [Related]  

  • 17. [Research advancement and prospects of nanotechnology in early diagnosis and treatment of cancer].
    Hu DH; Gong P; Ma YF; Cai LT
    Ai Zheng; 2009 Sep; 28(9):1000-3. PubMed ID: 19728922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons from immuno-oncology: a new era for cancer nanomedicine?
    Jiang W; Yuan H; Chan CK; von Roemeling CA; Yan Z; Weissman IL; Kim BYS
    Nat Rev Drug Discov; 2017 Jun; 16(6):369-370. PubMed ID: 28303024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The photonic nanomedicine revolution: let the human side of nanotechnology emerge.
    Halas NJ
    Nanomedicine (Lond); 2009 Jun; 4(4):369-71. PubMed ID: 19505237
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhancing quality of life as a goal for anticancer therapeutics.
    Pettit SD; Lipshultz SE; Cleeland CS; Roberts S; Davis M; Berridge BR; Kirch RA
    Sci Transl Med; 2016 Jun; 8(344):344ed9. PubMed ID: 27334258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.